Projects per year
Personal profile
Education
- 2008-2013 Ph.D., Department of Pharmacy, National Taiwan University
- 1996-1998 M.S., Department of Pharmacy, National Taiwan University
- 1992-1996 B.S., School of Pharmacy, Kaohsiung Medical University
Experience
- Researcher, Department of Medical Research, Taipei Medical University Hospital
- 2023.02- Associate Professor, Department of Pharmacology, College of Medicine, Taipei Medical University
- 2018.08-2023.01 Assistant Professor, Department of Pharmacology, College of Medicine, Taipei Medical University
- 2013.02-2017.07 Postdoctoral Research Fellow, Department and Graduate Institute of Pharmacology, College of Medicine, National Taiwan University
- 1999.09-2008.08 Pharmacist, National Taiwan University Hospital
- 1998.09-1999.08 Pharmacist, Linkou Chang Gung Memorial Hospital
Fingerprint
- 1 Similar Profiles
Network
-
Application of Novel Natural Naphthoquinone-Based Derivatives as Anti-Angiogenic, Anti-Lymphogenic and Anti-Tumor Agents and Its Underlying Mechanisms
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
新穎性結構天然物萘醌衍生物於血管及淋巴管新生抑制與抗腫瘤之應用及其機轉探討(2/3)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
結合奈米診斷治療、影像免疫基因圖譜與人工智慧於原發性與再復發膠質母細胞瘤之研究-開發新穎結構小分子抑制劑用來抑制血管生成和腫瘤微環境以治療原發性及復發性多型性神經膠質母細胞腦瘤患者(3/3)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
探討新穎小分子化合物影響三陰性乳癌細胞免疫檢查點之機制
7/1/21 → 2/28/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
結合奈米診斷治療、影像免疫基因圖譜與人工智慧於原發性與再復發膠質母細胞瘤之研究-開發新穎結構小分子抑制劑用來抑制血管生成和腫瘤微環境以治療原發性及復發性多型性神經膠質母細胞腦瘤患者(2/3)
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
Research output
- 21 Article
-
Anti-Angiogenetic and Anti-Lymphangiogenic Effects of a Novel 2-Aminobenzimidazole Derivative, MFB
Hsu, M. J., Chen, H. K., Chen, C. Y., Lien, J. C., Gao, J. Y., Huang, Y. H., Hsu, J. B. K., Lee, G. A. & Huang, S. W., Jun 20 2022, In: Frontiers in Oncology. 12, 862326.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Suppressing VEGF-A/VEGFR-2 Signaling Contributes to the Anti-Angiogenic Effects of PPE8, a Novel Naphthoquinone-Based Compound
Hsu, M. J., Chen, H. K., Lien, J. C., Huang, Y. H. & Huang, S. W., Jul 1 2022, In: Cells. 11, 13, 2114.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Detection of PD-L1 Expression in Temozolomide-Resistant Glioblastoma by Using PD-L1 Antibodies Conjugated with Lipid‑Coated Superparamagnetic Iron Oxide
Lee, G-A., Lin, W-L., Kuo, D. P., Li, Y-T., Chang, Y. W., Chen, Y-C., Huang, S-W., Hsu, J. B. K. & Chen, C-Y., Jul 2021, In: International Journal of Nanomedicine. 16, 16, p. 5233-5246 14 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Identification of Differentially Expressed Genes in Different Glioblastoma Regions and Their Association with Cancer Stem Cell Development and Temozolomide Response
Hsu, J. B-K., Lee, T-Y., Cheng, S-J., Lee, G. A., Chen, Y-C., Le, N. Q. K., Huang, S-W., Kuo, D-P., Li, Y-T., Chang, T-H. & Chen, C-Y., Nov 2021, In: Journal of Personalized Medicine. 11, 11, p. 1047 1047.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus) -
Lovastatin-mediated MCF-7 cancer cell death involves LKB1-AMPK-p38MAPK-p53-survivin signalling cascade
Huang, S. W., Chyuan, I. T., Shiue, C., Yu, M. C., Hsu, Y. F. & Hsu, M. J., Jan 1 2020, In: Journal of Cellular and Molecular Medicine. 24, 2, p. 1822-1836 15 p.Research output: Contribution to journal › Article › peer-review
Open Access32 Citations (Scopus)